A Safety and Pharmacokinetics Trial of VO659 in SCA1, SCA3 and HD

NCT05822908 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

68

Enrollment

INDUSTRY

Sponsor class

Conditions

Spinocerebellar Ataxia Type 1
Spinocerebellar Ataxia Type 3
Huntington Disease

Interventions

DRUG: VO659

Sponsor

Vico Therapeutics B. V.